AI MARKET SCANNING

iBio Inc

🏛️ NYSE 📁 Health Technology 🏭 Pharmaceuticals Other
AVG HISTORICAL GAP -1.30%
MAX GAP RECORD -4.97%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $IBIO
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 28, 2026 Earnings Release 2026-08-28 (BEFORE OPEN)
+1.43%
Feb 10, 2026 Earnings Release 2026-02-10 (AFTER CLOSE)
+2.20%
Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE)
-0.80%
Sep 05, 2025 Earnings Release 2025-09-05 (BEFORE OPEN)
+0.00%
May 02, 2025 Earnings Release 2025-05-02 (BEFORE OPEN)
-1.94%
Feb 10, 2025 Earnings Release 2025-02-10 (AFTER CLOSE)
-4.97%
Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE)
+0.00%
Sep 20, 2024 Earnings Release 2024-09-20 (AFTER CLOSE)
-3.05%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.2%
Bullish Gaps (2)
Bearish Gaps (4)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $IBIO

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗